| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Cbo | Chief Financial Officer | Executive Vice President &CFO
3 companies
Henderson Molly is a CFO And Cbo at Phathom Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 5 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 3,439 | $7.27 | $25,001.53 | -4.5% | +77.7% | +43.2% | |
| Mar 1, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 2,032 | $8.53 | $17,334.79 | -2.6% | +26.5% | +18.8% | |
| Nov 21, 2022 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 2,159 | $9.60 | $20,726.40 | -4.7% | -2.9% | -26.0% | |
| May 13, 2022 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Buy | 6,000 | $0.00 | - | +30.0% | +14.4% | +68.5% | |
| Jan 31, 2022 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 331 | $7.58 | $2,508.98 | -5.9% | -13.7% | +34.6% | |
| Nov 30, 2021 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Sale+OE | 2,587 | $12.03 | $31,121.61 | -34.5% | -50.4% | -29.1% | |
| May 17, 2021 | URGN Urogen Pharma Ltd. | Chief Financial Officer | Buy | 2,500 | $15.85 | $39,625.00 | New | -6.5% | -63.2% |